Meet Techcyte’s CMO and uncover the pathologist-first approach to digital pathology In this Thought Leaders episode, Sidney Ocanagil-Tunstall speaks with Dr. Tiffany Chen, Chief Medical Officer at Techcyte, about the realities of digital pathology adoption and what pathologists truly need from technology. The conversation explores workflow integration, AI in routine practice, trust in digital [...]
Key takeaways: Three-quarters of hem/onc fellows report using AI tools but only 8% received formal AI training. This may lead to inconsistent use, overreliance, de-skilling or uncertainty about accuracy. Hematology/oncology fellows have embraced AI for educational or clinical purposes but they rarely receive formal training to guide use of these tools, according to survey results [...]
The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Joshua W. Tashman, Chris Gorman, Emilio [...]
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine, Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of a digital pathology IMS Open-Source Consortium (“IMS Consortium”). Designed to accelerate the democratization and standardization of digital pathology, the consortium aims to bring together [...]
Leica Biosystems, a Danaher company and a global leader in end‑to‑end anatomic and digital pathology solutions, is advancing how pharmaceutical organizations scale digital and computational pathology to support AI‑enabled biomarker discovery and companion diagnostics (CDx) development. The company recently convened senior leaders from leading pharmaceutical companies along with academic and clinical experts from top organizations for [...]
by Rajendra Singh MD Professor of Pathology, University of Pennsylvania Co-Founder, PathPresenter TROP2, Tissue, and the Missing Spatial Dimension Last week, I wrote that the future of pathology would not be defined by any single technology—not AI, not molecular testing, and not digital pathology alone. Rather, the future belongs to those who can [...]
Pathology workflows today are riddled with complexity—multiple logins, fragmented tools, and siloed systems. But what if one platform could bring it all together? In this episode of Digital Pathology Place, I talk with Ben Cahoon, CEO, and Dr. Tiffany Chen, Chief Medical Officer of TechCyte, about Fusion—a next-generation digital pathology platform built to unify clinical and anatomic pathology, AI diagnostics, and smart reporting into [...]
by Christos Evangelou, MSc, PhD – Medical Writer and Editor Researchers at Rutgers Health and the University of Pittsburgh Medical Center developed a multiresolution deep learning tool to address interobserver variability in risk stratification for potentially malignant oral lesions. The model demonstrated 80% accuracy and outperformed both traditional pathology grading systems and human pathologists in identifying oral lesions likely to progress into malignant lesions. The study was published [...]
Digital pathology is transforming the way pathology laboratories operate, collaborate, and deliver diagnostic insights. While some laboratories adopt a hybrid approach, using digital pathology only for selected cases such as second opinions or tumor boards, this model often limits the true clinical and operational value of digital transformation1. In hybrid laboratories, pathologists continue to divide their [...]
Techcyte today announced that Northwest Arkansas Pathology Associates, PA (NWAPath) has implemented the Techcyte Fusion platform in its laboratory, enabling remote pathology workflows designed to address ongoing staffing challenges and improve access to specialized expertise.Like many pathology groups, NWAPath has faced increasing difficulty recruiting and retaining qualified pathologists locally. By adopting Techcyte Fusion AP, the group is able to [...]
